NB-598: a potent competitive inhibitor of squalene epoxidase.
NB-598, (E)N-ethyl-N-(6,6-dimethyl-2-hepten-4-ynyl)-3-[(3,3'-bith iophen-5-yl)methoxy]benzene-methanamine, was found to inhibit human microsomal squalene epoxidase (from Hep G2 cells) in a competitive manner. NB-598 inhibited cholesterol synthesis from [14C]acetate dose dependently in Hep G2 cells and increased the intracellular radioactivity of squalene. A single oral administration of NB-598 inhibited cholesterol synthesis from [14C]acetate in rats. Moreover, multiple oral administration of NB-598 to dogs decreased serum total and low density lipoprotein cholesterol levels and increased serum squalene levels. After termination of treatment, the reduced serum cholesterol and increased squalene levels returned to their control values.
Central Research Laboratories, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.
M
M
Horie
Y
Y
Tsuchiya
M
M
Hayashi
Y
Y
Iida
Y
Y
Iwasawa
Y
Y
Nagata
Y
Y
Sawasaki
H
H
Fukuzumi
K
K
Kitani
T
T
Kamei
D000818:Animals; D000924:Anticholesteremic Agents; D001596:Benzylamines / Q000494:pharmacology*; D002417:Cattle; D002460:Cell Line; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D050356:Lipid Metabolism; D010105:Oxygenases / Q000037:antagonists & inhibitors*; D051381:Rats; D013185:Squalene / Q000378:metabolism*; D050603:Squalene Monooxygenase; D013876:Thiophenes / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D001596:Benzylamines; D013876:Thiophenes; C066059:NB 598; D013185:Squalene; D002784:Cholesterol; D010105:Oxygenases; D050603:Squalene Monooxygenase